Charles River Laboratories International, Inc.
Location
Massachusetts
Founded
1947-02-28
Website
Risk Signals
1069 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research, Testing Laboratories), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Charles River Laboratories International, Inc.
Live alerts from global media, monitored by Business Radar
2022-10-04 (finsmes.com)
Wheeler Bio Holds Initial Closing of Series A Funding Round
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Read more
2021-06-29 (technical.ly)
M&A Moves: 2U acquired edX for $800M from Harvard, MIT
Plus, Ellucian gets acquired by the Blackstone Group and Charles River Laboratories International acquires Rockville biotech company Vigene Biosciences.
Read more
2020-06-01 (abladvisor.com)
Asset Based Lending Industry News, Financial Articles, Blogs, Economic Data, Deal Tables, Company Directories for ABL Professionals
Marathon Asset Management Closes$ 50MM Credit Facility With Baudax Bio Baudax Bio, Inc., a pharmaceutical company focused on therapeutics for acute care settings, today announced that it has closed on a credit facility of up to$ 50 million from funds
Read more
2010-04-26 (massdevice.com)
Charles River Labs to pay $1.6 billion for WuXi PharmaTech
Charles River Laboratories International Inc. (NYSE:CRL) didn’t let disappointing first-quarter results slow it down, inking a $1.6 billion cash-and-stock deal to acquire Shanghai-based WuXi PharmaTech (Cayman) Inc. (NYSE:WX). The Winchester,
Read more
(financeasia.com)
Charles River takeover of WuXi collapses
Charles River bows to shareholder pressure and abandons its $1.6 billion takeover of WuXi PharmaTech, signalling that Western buyers may find it difficult to garner the support they need to strike deals in Asia's fast-growing economies.
Read more